Phase I/II Study of Azacitidine, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy

Title
Phase I/II Study of Azacitidine, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy
Authors
Keywords
Chemotherapy, GADD45A, Methylation, Taxotere, Vidaza
Journal
Clinical Genitourinary Cancer
Volume 13, Issue 1, Pages 22-31
Publisher
Elsevier BV
Online
2014-08-02
DOI
10.1016/j.clgc.2014.07.008

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now